Fundraising FoxSpirrow Therapeutics
1 known investors
Find your way into Spirrow Therapeutics
Sign up to see every warm intro you have to Spirrow Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Spirrow Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Spirrow Therapeutics develops a first-in-kind polymer lung surfactant (PLS) based on nanotechnology to treat acute respiratory distress syndrome (ARDS), with a focus on restoring lung function in infants. The therapy is designed to reduce alveolar surface tension and fluid accumulation in the lungs.
Founders & leadership
Investors · 1
Elevate Ventureslisted by Elevate VenturesIndianapolis · $20K – $2M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Spirrow Therapeutics do?
- Spirrow Therapeutics develops a first-in-kind polymer lung surfactant (PLS) based on nanotechnology to treat acute respiratory distress syndrome (ARDS), with a focus on restoring lung function in infants. The therapy is designed to reduce alveolar surface tension and fluid accumulation in the lungs.
- Who founded Spirrow Therapeutics?
- Spirrow Therapeutics was founded by Davis Arick.
- Who are Spirrow Therapeutics's investors?
- Spirrow Therapeutics's investors include Elevate Ventures.